Dave Davies

And she went to Bologi, the doctor, and he said, try it?

And she went to Bologi, the doctor, and he said, try it?

So the doctor who was treating Jimmy, this multiple myeloma patient, I guess was involved in a study of 89 patients or so, I guess. And the results showed what?

So the doctor who was treating Jimmy, this multiple myeloma patient, I guess was involved in a study of 89 patients or so, I guess. And the results showed what?

So the doctor who was treating Jimmy, this multiple myeloma patient, I guess was involved in a study of 89 patients or so, I guess. And the results showed what?

So it turns out there's a company called Celgene that held the patent for thalidomide. What did this discovery do to their financial position?

So it turns out there's a company called Celgene that held the patent for thalidomide. What did this discovery do to their financial position?

So it turns out there's a company called Celgene that held the patent for thalidomide. What did this discovery do to their financial position?

It's interesting that when they were using the thalidomide-based drug to treat AIDS patients, they kept the prices low. And there was an interesting explanation for this, which did not apply to the multiple myeloma patients. Do you want to explain that?

It's interesting that when they were using the thalidomide-based drug to treat AIDS patients, they kept the prices low. And there was an interesting explanation for this, which did not apply to the multiple myeloma patients. Do you want to explain that?

It's interesting that when they were using the thalidomide-based drug to treat AIDS patients, they kept the prices low. And there was an interesting explanation for this, which did not apply to the multiple myeloma patients. Do you want to explain that?

Because multiple myeloma patients wouldn't protest?

Because multiple myeloma patients wouldn't protest?

Because multiple myeloma patients wouldn't protest?

So we were saying that there was this discovery that thalidomide, this drug which had such a terrible reputation for causing birth defects, proved effective in treating multiple myeloma. And the patent was held by Celgene, this little pharmaceutical company. And it's interesting. You write that, I guess, not all patents are created equal. Celgene's patent was limited in a way.

So we were saying that there was this discovery that thalidomide, this drug which had such a terrible reputation for causing birth defects, proved effective in treating multiple myeloma. And the patent was held by Celgene, this little pharmaceutical company. And it's interesting. You write that, I guess, not all patents are created equal. Celgene's patent was limited in a way.

So we were saying that there was this discovery that thalidomide, this drug which had such a terrible reputation for causing birth defects, proved effective in treating multiple myeloma. And the patent was held by Celgene, this little pharmaceutical company. And it's interesting. You write that, I guess, not all patents are created equal. Celgene's patent was limited in a way.

How and why does this matter?

How and why does this matter?

How and why does this matter?